The US government stops the distribution of Eli Lilly Covid-19 antibody treatment


The US government in coordination with Eli Lilly said it will no longer distribute the Covid-19 monoclonal antibody therapy bamlanivimab for use on its own. The halt is due to the "sustained increase" in coronavirus variants in the United States.

To see more of this story, please click right here.

0 comments